Thoughts on Drug Regulatory Science in the New Era
MAO Zhenbin1*, WANG Ying1,2, WANG Siming1,3
1 National Medical Products Administration, Beijing 100037, China; 2 National Institutes for Food and Drug Control, Beijing 100050, China; 3 Shenzhen Institute for Drug Control, Shenzhen Guangdong 518057, China
Abstract：This paper describes the course of development and significance of regulatory science, and attempts in-depth thinking about the application of drug regulatory science in China in the new era. We discussed the birth and beginning of regulatory science, the development and achievement of drug regulatory science, the essence and characteristic of regulatory science, the effect and duty of regulatory science. Through the study of the strategies and implementation method path, this paper specifies the direction in which the regulatory science systems for Traditional Chinese medicine and modern pharmaceuticals of the world level are to be established.
毛振宾, 王迎, 王思明. 新时代药品监管科学研究与思考[J]. 中国药物警戒, 2020, 17(4): 193-197.
MAO Zhenbin, WANG Ying, WANG Siming. Thoughts on Drug Regulatory Science in the New Era. Chinese Journal of Pharmacovigilance, 2020, 17(4): 193-197.
[1] 杨悦. 监管科学的起源[J]. 中国食品药品监管,2019(4):13-23. [2] 赵嘉,谭德讲,高泽诚,等.监管科学的起源定义及作用[J]. 中国药事,2014,28(12):1290-1293. [3] Weinberg AM.Science and Trans-science[J].Minerva,1972(10):209-222. [4] 刘昌孝. 国际药品监管科学发展概况[J]. 药物评价研究,2017,40(8):1029-1043. [5] Wikipedia.Regulatory science[EB/OL].(2017-06-17)[2020-01-06].https://en.wikipedia.org/ wiki/Regulatory_science. [6] Kurihara C, Saio T.What is the Regulatory Science? Concept andHistory in United States and in Japan - Interview with ProfessorSheila Jasanoff[J]. Chin Eval,2011,39(1):1-16. [7] 川西徹. 先端的医薬品の開発に向けたレギュラトリーサイエンス研究[J]. 日薬理誌, 2016(148):272-277. [8] 内山充. RegulatoryScience [N]. 衛研支部ニュース(全厚生職員労働組合国立衛生研究所支部),1987(272). [9] Moghissi AA,et al.Ruckelshaus Effect[J]. Synesis: A Journal ofScience, Technology,Ethics,And Policy,2012,3(1):G6-G13. [10] Jasanoff S.TheFifthBranch: ScienceAdvisorsasPolicymakers [M].Harvard University Press,1990:80. [11] 张怡,王晨光.监管科学的兴起及其对各国药品监管的影响[J].中国食品药品监管,2019(7):21-29. [12] FDA. Advancing Regulatory Science at FDA: A Strategic Plan [R].Marryland:FDA, 2011. [13] FDA. Advancing Regulatory Science at FDA: A Strategic Plan [R].Marryland:FDA, 2011. [14] EMA. Regulatory Science to 2025: Strategic reflection[R].EMA, 2018. [15] FDA.Food and Drug Administration Safety and Innovation Act.21USC 301[EB/OL].(2012-08-10)[2020-01-06].https://www.fda.gov/safety. [16] FDA. Strategy and Implementation Plan for Advancing RegulatoryScience[R]. Marryland:FDA, 2013. [17] FDA. FY 2013-2014 Regulatory Science Progress Report[R].Marryland:FDA, 2014. [18] De Vries C.EMA support to and involvement in regulatory science-HCPWP workshop on the framework of collaboration withacademia [R]. EMA, 2016. [19] Kurihara C,Saio T.What is the Regulatory Science? Conceptand History in United States and in Japan-Interview withProfessor Sheila Jasanoff[J]. Chin Eval,2011,39(1):1-16.
2020, Vol. 17 
